Strand Therapeutics develops new class of mRNA molecules for cancer
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Read More
Tag: immunotherapies
Poolbeg’s cytokine release syndrome drug shows potential
Data supports Poolbeg’s strategic expansion of POLB 001
Read More
Affimed ties with Roche in cancer immunotherapies deal
Shares in Affimed more than doubled on news that it has signed a deal with Roche group Genentech to develop immunotherapies for various cancers.
Read More
Scotland’s TCB inks CAR-T deal with Japan’s NIPRO
Scotland’s TC Biopharm (TCB) has secured a major investment from Japan with a deal centered on developing a novel gamma-delta CAR-T therapy to treat cancer, as well as a grant from Scottish Enterprise worth £2.7 million to fund preclinical activities.
Read More
Global drug sales forecast to take a downturn
For the first time in 10 years global sales of pharmaceuticals are forecast by Evaluate to take a downturn because of growing pricing pressures.
Read More
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
